首页> 外国专利> RECOMBINANT ANTIGEN BASED RAPID SERO-DIAGNOSIS OF INFECTIOUS BURSAL DISEASE (IBD)

RECOMBINANT ANTIGEN BASED RAPID SERO-DIAGNOSIS OF INFECTIOUS BURSAL DISEASE (IBD)

机译:基于重组抗原的传染性法氏囊病(IBD)快速血清学诊断

摘要

A yeast expressed recombinant VP2 antigen based latex agglutination test (LAI) was developed to measure the specific antibody in sera of chickens against Infectious bursal disease virus. Infectious bursal disease virus (IBDV), belonging to the family Birnaviridae, exhibits an immunosuppressive disease of young chicken characterized by severe depletion of B-lymphocytes in the bursa of Fabricius. The major immunogenic capsid gene VP2 was cloned and expressed from the yeast Saccharomyces cerevisiae. Serological diagnosis is commonly performed with Agar gel immunoprecipitation test (AGPT), virus neutralization (VN) or Enzyme linked immunosorbent assay (ELISA). The recombinant VP2 antigen based kit when tested against a panel of chicken serum samples proved to be more sensitive and specific than AGPT. The recombinant VP2 protein could be simpler and safer to produce in bulk from yeast system and have higher sensitivity and specificity as the target antigen is immunodominant and devoid of any non specific moieties as present in whole cell preparations. The test is extremely simple and novel and not labour intensive like VN and does not require a virology laboratory. The test also does not require the usage of sophisticated equipments like ELISA reader and the results are proved to be sensitive, specific and accurate as compared to ELISA. Moreover the test can be performed in the field conditions and the sensitized latex coated beads could be stored at 4°C for more than 4 months and at ambient temperature for a month without the loss of activity for both weakly and strongly positive samples. Key words: Infectious bursal disease virus- recombinant VP2 antigen-yeast expression -Latex agglutination test- diagnosis
机译:开发了一种基于酵母表达的重组VP2抗原的乳胶凝集试验(LAI),以测量鸡血清中针对传染性法氏囊病病毒的特异性抗体。传染性法氏囊病病毒(IBDV)属于伯纳维亚科(Birnaviridae),表现出雏鸡的免疫抑制疾病,其特征是Fabricius囊中的B淋巴细胞严重耗竭。从酿酒酵母中克隆并表达了主要的免疫原性衣壳基因VP2。血清学诊断通常通过琼脂凝胶免疫沉淀试验(AGPT),病毒中和(VN)或酶联免疫吸附测定(ELISA)进行。当针对一组鸡血清样品进行测试时,基于重组VP2抗原的试剂盒比AGPT更加灵敏和特异。重组VP2蛋白可以更简单,更安全地从酵母系统中批量生产,并且具有更高的敏感性和特异性,因为目标抗原具有免疫优势,并且没有全细胞制剂中存在的任何非特异性部分。该测试极其简单新颖,并且不需要像VN那样费力的工作,并且不需要病毒学实验室。该测试也不需要使用诸如ELISA读取器之类的复杂设备,并且与ELISA相比,结果被证明是灵敏,特异和准确的。而且,该测试可以在野外条件下进行,并且敏化的乳胶涂层的珠子可以在4°C下保存4个月以上,在环境温度下可以保存一个月,而对于弱阳性和强阳性样品均不会失去活性。关键词:传染性法氏囊病病毒-重组VP2抗原-酵母表达-乳胶凝集试验-诊断

著录项

  • 公开/公告号IN277404B

    专利类型

  • 公开/公告日2016-11-25

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN491/DEL/2008

  • 发明设计人 DR. JAG MOHAN KATARIA;

    申请日2008-03-03

  • 分类号

  • 国家 IN

  • 入库时间 2022-08-21 13:38:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号